PharmaCorp Rx Inc. (TSXV:PCRX)

PharmaCorp Rx Revenue

In the year 2025, PharmaCorp Rx had annual revenue of 20.89M CAD with 260.57% growth. PharmaCorp Rx had revenue of 7.69M in the quarter ending December 31, 2025, with 74.80% growth.

• Revenue: 20.89M
• Revenue Growth: +260.57%
• P/S Ratio: 4.25
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 88.78M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	20.89M	15.10M	260.57%
Dec 31, 2024	5.79M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error